Showing results (11-20 of 22) with videos related to
Sort By:
Pageof 3
Clinical Chemistry|July 27, 2002
Measurement of the noncomplexed free fraction of tissue inhibitor of metalloproteinases 1 in plasma by immunoassayMads N Holten-Andersen, Ib Jarle Christensen, Hans Jørgen Nielsen, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 6, 2000
High preoperative plasma tissue inhibitor of metalloproteinase-1 levels are associated with short survival of patients with colorectal cancerM N Holten-Andersen, R W Stephens, H J Nielsen, et al.European Journal of Cancer (Oxford, England : 1990)|September 3, 2004
Plasma TIMP-1 in patients with colorectal adenomas: a prospective studyMads N Holten-Andersen, Claus Fenger, Hans Jørgen Nielsen, et al.European Journal of Haematology|September 3, 2003
Collagen metabolism and enzymes of the urokinase plasminogen activator system in chronic myeloproliferative disorders: correlation between plasma-soluble urokinase plasminogen activator receptor and serum markers for collagen metabolismMorten Krogh Jensen, Rikke Riisbro, Mads N Holten-Andersen, et al.The International Journal of Biological Markers|May 23, 2006
Levels of tissue inhibitor of metalloproteinases 1 in plasma and urine from patients with bladder cancerM N Holten-Andersen, N Brünner, H J Nielsen, et al.British Journal of Cancer|July 17, 1999
Quantitation of TIMP-1 in plasma of healthy blood donors and patients with advanced cancerM N Holten-Andersen, G Murphy, H J Nielsen, et al.Acta Paediatrica (Oslo, Norway : 1992)|July 13, 2019
No significant associations between breastfeeding practices and overweight in 8-year-old childrenAsborg A Bjertnaes, Jacob H Grundt, Hilde M Donkor, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 23, 2006
Primary tumor levels of tissue inhibitor of metalloproteinases-1 are predictive of resistance to chemotherapy in patients with metastatic breast cancerAnne-Sofie Schrohl, Marion E Meijer-van Gelder, Mads N Holten-Andersen, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 10, 2004
Tumor tissue levels of tissue inhibitor of metalloproteinase-1 as a prognostic marker in primary breast cancerAnne-Sofie Schrohl, Mads N Holten-Andersen, Harry A Peters, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 22, 2002
Total levels of tissue inhibitor of metalloproteinases 1 in plasma yield high diagnostic sensitivity and specificity in patients with colon cancerMads N Holten-Andersen, Ib Jarle Christensen, Hans Jørgen Nielsen, et al.Pageof 3